News

The Department of Disease Control (DDC) has begun administering monkeypox (Mpox) vaccinations to medical personnel.
Mpox is a rare, but potentially serious, viral illness that typically involves flu-like symptoms, swollen lymph nodes and a ...
TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox. TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa ...
The World Health Organization (WHO) and Africa Centre for Disease Control and Prevention (Africa CDC) have updated their ...
The antiviral drug tecovirimat (Tpoxx) didn't accelerate lesion clearance in adults and children with clade 1 mpox participating in a randomized controlled trial in the Democratic Republic of the ...
Mpox can be lethal, especially for children under five years old. The mortality rate for clade I is between 3% and 10%. The ...
Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.
Early in the morning, the committee considered whether to revise a previous recommendation for Jynneos, the vaccine for mpox, which had sparked a 2022 outbreak that disproportionately affected ...
The Maine CDC is excited to announce that we are modernizing our Tuberculosis (TB) reporting system. Currently, inactive TB (also known as Latent TB Infection or LTBI) cases and suspect and confirmed ...
The new vaccine is a replication-deficient vaccine based on a modified vaccinia Ankara (MVA) strain, similar to Jynneos, the world's first mpox vaccine, developed by Danish company Bavarian Nordic.
There are currently two vaccines including JYNNEOS and ACAM2000 approved by the US Food and Drug Administration (US FDA) for the prevention of mpox and smallpox diseases in adults of 18 years of ...
The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox and mpox vaccine, live, non-replicating). Prior to this approval, Jynneos had only been ...